PL2928861T3 - Pochodne aminocyklobutanu, sposób ich wytwarzania i ich zastosowanie jako leki - Google Patents

Pochodne aminocyklobutanu, sposób ich wytwarzania i ich zastosowanie jako leki

Info

Publication number
PL2928861T3
PL2928861T3 PL13811402T PL13811402T PL2928861T3 PL 2928861 T3 PL2928861 T3 PL 2928861T3 PL 13811402 T PL13811402 T PL 13811402T PL 13811402 T PL13811402 T PL 13811402T PL 2928861 T3 PL2928861 T3 PL 2928861T3
Authority
PL
Poland
Prior art keywords
drugs
preparing same
aminocyclobutane
derivatives
aminocyclobutane derivatives
Prior art date
Application number
PL13811402T
Other languages
English (en)
Inventor
Bernard Vacher
Elodie Blanc
Ronan Depoortere
Original Assignee
Pierre Fabre Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament filed Critical Pierre Fabre Medicament
Publication of PL2928861T3 publication Critical patent/PL2928861T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/14—Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL13811402T 2012-12-04 2013-12-04 Pochodne aminocyklobutanu, sposób ich wytwarzania i ich zastosowanie jako leki PL2928861T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1261621A FR2998892B1 (fr) 2012-12-04 2012-12-04 Derives d'aminocyclobutane, leur procede de preparation et leur utilisation a titre de medicaments
EP13811402.0A EP2928861B1 (fr) 2012-12-04 2013-12-04 Dérivés d'aminocyclobutane, leur procédé de préparation et leur utilisation à titre de médicaments

Publications (1)

Publication Number Publication Date
PL2928861T3 true PL2928861T3 (pl) 2017-08-31

Family

ID=48128432

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13811402T PL2928861T3 (pl) 2012-12-04 2013-12-04 Pochodne aminocyklobutanu, sposób ich wytwarzania i ich zastosowanie jako leki

Country Status (30)

Country Link
US (2) US9469601B2 (pl)
EP (1) EP2928861B1 (pl)
JP (1) JP6391586B2 (pl)
KR (1) KR102221928B1 (pl)
CN (2) CN106957285B (pl)
AR (1) AR093787A1 (pl)
AU (1) AU2013354133B2 (pl)
BR (1) BR112015012752B1 (pl)
CA (1) CA2893216C (pl)
CY (1) CY1118841T1 (pl)
DK (1) DK2928861T3 (pl)
ES (1) ES2621896T3 (pl)
FR (1) FR2998892B1 (pl)
HR (1) HRP20170564T1 (pl)
IL (1) IL239146A (pl)
LT (1) LT2928861T (pl)
MA (1) MA38229B1 (pl)
MX (1) MX364556B (pl)
MY (1) MY179886A (pl)
NZ (1) NZ709572A (pl)
PL (1) PL2928861T3 (pl)
PT (1) PT2928861T (pl)
RS (1) RS55916B1 (pl)
RU (1) RU2655919C2 (pl)
SA (1) SA515360518B1 (pl)
SI (1) SI2928861T1 (pl)
TN (1) TN2015000240A1 (pl)
TW (1) TWI603947B (pl)
UA (1) UA114017C2 (pl)
WO (1) WO2014086825A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7279067B2 (ja) 2018-03-28 2023-05-22 武田薬品工業株式会社 複素環化合物及びその用途
JP2021050161A (ja) 2019-09-25 2021-04-01 武田薬品工業株式会社 複素環化合物及びその用途
WO2021098732A1 (zh) * 2019-11-18 2021-05-27 江苏恩华药业股份有限公司 一种1',2'-二氢-3'h-螺[环丁烷1,4'-异喹啉]-3'-酮衍生物及其应用
CN115353489A (zh) * 2021-05-17 2022-11-18 苏州恩华生物医药科技有限公司 一种氘代酰胺类衍生物及其应用
CN116425677B (zh) * 2022-01-11 2026-04-14 苏州恩华生物医药科技有限公司 氨基环丁烷衍生物的盐、其晶型及其制备方法和应用
CN116715632B (zh) * 2022-03-07 2025-09-30 苏州恩华生物医药科技有限公司 螺[环丁烷1,4′-异喹啉]酮类衍生物顺反异构体的制备方法
CN119143701B (zh) * 2023-06-16 2025-11-18 北京大学 一种[2.1.1]桥环内酯单体和可回收聚酯及其制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133924A (en) * 1960-05-31 1964-05-19 Bristol Myers Co Amino-substituted cyclobutane carboxamides
FR2581059B1 (fr) * 1985-04-25 1988-04-22 Pf Medicament Procede de preparation du chlorhydrate de phenyl-1 diethyl amino carbonyl-1 aminomethyl-2 cyclopropane (z)
WO1995022521A1 (en) * 1994-02-22 1995-08-24 Asahi Kasei Kogyo Kabushiki Kaisha Aminoalkylcyclopropane derivative
US6197830B1 (en) 1995-09-22 2001-03-06 Bruce M. Frome Method for achieving relief from sympathetically mediated pain
WO1998007447A1 (en) 1996-08-23 1998-02-26 Algos Pharmaceutical Corporation Anticonvulsant containing composition for treating neuropathic pain
JP3782935B2 (ja) 1997-09-08 2006-06-07 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 抗癲癇化合物を含有する鎮痛剤組成物およびその使用方法
US6118017A (en) 1998-04-14 2000-09-12 Smithkline Beecham Corporation Substituted-(3-cyclopentyloxy-4-methoxyphenyl)-3-phenylcyanocyclobutan-1-one
BR9912827A (pt) 1998-07-16 2001-05-02 Sloan Kettering Inst Cancer Composições tópicas compreendendo um analgésico opióide e um antagonista de nmda
US6362201B1 (en) 1999-03-02 2002-03-26 Merck & Co., Inc. 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity
US7820688B2 (en) 2001-04-27 2010-10-26 Memorial Sloan-Kettering Cancer Center Topical anesthetic/opioid formulations and uses thereof
EP1471909A4 (en) 2002-01-16 2007-07-25 Endo Pharmaceuticals Inc PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM
TW200307539A (en) * 2002-02-01 2003-12-16 Bristol Myers Squibb Co Cycloalkyl inhibitors of potassium channel function
US7687080B2 (en) 2002-11-25 2010-03-30 Taraxos Inc. Treatment of neuropathy
EP1845995A4 (en) 2005-01-25 2010-03-03 Glaxo Group Ltd ANTIBACTERIAL AGENTS
AR065137A1 (es) 2007-02-01 2009-05-20 Tibotec Pharm Ltd Procesos e intermediarios para la preparacion de un inhibidor de proteasa macrociclico del vhc y metodos de obtencion de los mencionados intermediarios.
BRPI0809843A2 (pt) * 2007-04-26 2014-09-23 Auspex Pharmaceuticals Inc "composto, composição farmacêutica e uso de um composto"
US20090061024A1 (en) 2007-08-27 2009-03-05 Wyeth Compositions and methods employing nmda antagonists for achieving an anesthetic-sparing effect
BRPI0819795B8 (pt) 2007-11-28 2021-05-25 Astellas Pharma Inc compostos de indano fundidos e seus usos no tratamento de doenças relacionadas ao receptor nmda, bem como composição farmacêutica compreendendo os mesmos
CN102066345B (zh) 2008-01-16 2013-07-17 生物科技研究有限公司 *唑烷衍生物作为nmda拮抗剂
WO2010036937A1 (en) 2008-09-27 2010-04-01 Taraxos Inc. Topical formulations for treatment of neuropathy
TW201026667A (en) 2008-09-30 2010-07-16 Merz Pharma Gmbh & Co Kgaa Glycine b antagonists
FR2943666B1 (fr) 2009-03-31 2011-04-15 Commissariat Energie Atomique Metallophore derive de nicotianamine et ses procedes de fabrication
FR2944011B1 (fr) * 2009-04-03 2011-05-20 Pf Medicament Derives d'aminocyclobutane ou d'aminocyclobutene, leur procede de preparation et leur utilisation a titre de medicaments.
CA2759951C (en) * 2009-05-07 2017-05-02 Gruenenthal Gmbh Substituted phenylureas and phenylamides as vanilloid receptor ligands
FR2946535B1 (fr) 2009-06-10 2011-09-09 Neureva Composition comprenant une molecule favorisant l'interaction neurone-glie, notamment pour prevenir la formation de la cicatrice gliale et induire la regeneration neurale.
TWI544923B (zh) 2009-12-29 2016-08-11 何應瑞 用於治療神經退化性疾病之醫藥組合物

Also Published As

Publication number Publication date
US9469601B2 (en) 2016-10-18
JP2016502555A (ja) 2016-01-28
TN2015000240A1 (fr) 2016-10-03
ES2621896T3 (es) 2017-07-05
CN106957285B (zh) 2019-05-03
US20170065543A1 (en) 2017-03-09
IL239146A (en) 2017-06-29
MA38229A1 (fr) 2016-01-29
CA2893216C (fr) 2021-01-26
CN104854083B (zh) 2017-05-24
EP2928861B1 (fr) 2017-01-11
MX2015006686A (es) 2015-08-10
PT2928861T (pt) 2017-04-24
JP6391586B2 (ja) 2018-09-19
FR2998892A1 (fr) 2014-06-06
CA2893216A1 (fr) 2014-06-12
FR2998892B1 (fr) 2015-01-02
AU2013354133A1 (en) 2015-07-23
CN106957285A (zh) 2017-07-18
SA515360518B1 (ar) 2017-05-17
MY179886A (en) 2020-11-18
LT2928861T (lt) 2017-04-25
AR093787A1 (es) 2015-06-24
MX364556B (es) 2019-04-30
IL239146A0 (en) 2015-07-30
BR112015012752A2 (pt) 2017-07-11
RS55916B1 (sr) 2017-09-29
DK2928861T3 (en) 2017-04-24
WO2014086825A1 (fr) 2014-06-12
UA114017C2 (xx) 2017-04-10
MA38229B1 (fr) 2016-09-30
NZ709572A (en) 2019-02-22
TWI603947B (zh) 2017-11-01
US9687459B2 (en) 2017-06-27
RU2015126104A (ru) 2017-01-10
HK1212968A1 (zh) 2016-06-24
AU2013354133B2 (en) 2017-07-06
KR20150091163A (ko) 2015-08-07
EP2928861A1 (fr) 2015-10-14
RU2655919C2 (ru) 2018-05-30
HRP20170564T1 (hr) 2017-06-16
SI2928861T1 (sl) 2017-05-31
CN104854083A (zh) 2015-08-19
TW201427930A (zh) 2014-07-16
CY1118841T1 (el) 2018-01-10
BR112015012752B1 (pt) 2020-10-27
US20150315132A1 (en) 2015-11-05
KR102221928B1 (ko) 2021-03-02

Similar Documents

Publication Publication Date Title
AP4028A (en) New indolizine derivatives, method for preparing same and pharmaceutical compositions containing same
ZA201404625B (en) Polycyclic derivatives, preparation method and medical uses thereof
IL245101A0 (en) Derivatives of 1,4-cyclohexylamine and processes for their preparation
IL266300B (en) Antecedents of glutarimide, their use, a pharmaceutical preparation based on them and methods for producing antecedents of glutarimide
SG11201600318RA (en) Novel indolizine derivatives, method for the production thereof and pharmaceutical compositions containing same
ZA201407021B (en) Novel thienopyrimidine derivatives,processes for the preparation thereof and therapeutic uses thereof
EP2763998A4 (en) TRI-HETEROCYCLIC DERIVATIVES, MANUFACTURING METHOD AND USES THEREOF
IL239146A0 (en) Aminocyclobutane derivatives, methods for their preparation and their use as drugs
EP2924042A4 (en) BIS-BETA-CARBOLINE COMPOUND AND METHOD OF MANUFACTURING, PHARMACEUTICAL COMPOSITION AND USE THEREOF
ZA201309559B (en) Comptothecin derivative, method for preparing same, pharmaceutical composition and use thereof
ZA201501985B (en) Combination drug comprising gemigliptin and metformin,and method for the preparation thereof
EP3037099A4 (en) Pharmaceutical composition, preparation method therefor and use thereof
EP2805954A4 (en) 7-SUBSTITUTED HANFANGICHIN B DERIVATIVE AND MANUFACTURING METHOD AND USE THEREOF
IL252033B (en) History of spiro and processes for their preparation
IL227544A0 (en) Leoplomide and its enantiomers, a method for their preparation and medical uses thereof
PT2870145T (pt) Derivados de indeno, sua preparação e utilização como medicamentos
HUE050104T2 (hu) 3,5N-trihidroxi-alkánamid és származékok: eljárás ennek elõállítására és ennek felhasználása
AP3759A (en) Method for preparing phenyloxymethyl-nitro-imidazole derivatives and use of the same
PL398021A1 (pl) Nowa diacylo-sn-glicero-3-fosfocholina oraz sposób jej otrzymywania
PL398018A1 (pl) Nowa diacylo-sn-glicero-3-fosfocholina oraz sposób jej otrzymywania
PL398496A1 (pl) Iminowa pochodna (-)-fenchonu i sposób jej wytwarzania
PL398987A1 (pl) (Z)-6-siarczan-6,4'-dihydroksy-7-prenylo-4-metoksyauronu i sposób jego wytwarzania
HUP1300393A2 (en) Quinazoline derivatives, process for the preparation thereof and pharmaceutical compositions comprising the same
PL395175A1 (pl) Nowe pochodne dekstrometorfanu i sposób ich wytwarzania